Elizabeth L McQuaid1. 1. Department of Psychiatry and Human Behavior, Alpert Medical School, Brown University, Providence, Rhode Island; Department of Pediatrics, Alpert Medical School, Brown University, Providence, Rhode Island. Electronic address: elizabeth_mcquaid@brown.edu.
Abstract
OBJECTIVE: Significant disparities exist in asthma outcomes. Racial and ethnic minorities have lower controller medication adherence, which may contribute to differences in asthma morbidity between minority and non-minority groups. The objective of this review is to identify individual, patient-provider communication, and systems issues that contribute to this pattern of medication underuse and to discuss potential strategies for intervention. DATA SOURCES: Data were gathered from numerous sources, including reports of pharmacy and medical records, observational studies, and trials. STUDY SELECTIONS: Studies analyzed factors contributing to patterns of asthma medication adherence that differ by race and ethnicity. RESULTS: There is clear evidence of underuse of asthma controller medications among racial and ethnic minorities in prescription receipt, prescription initiation, and medication use once obtained. Individual factors such as medication beliefs and depressive symptoms play a role. Provider communication is also relevant, including limited discussion of complementary and alternative medicine use, difficulties communicating with patients and caregivers with limited English proficiency, and implicit biases regarding cultural differences. Systems issues (eg, insurance status, cost) and social context factors (eg, exposure to violence) also present challenges. Culturally informed strategies that capitalize on patient strengths and training providers in culturally informed communication strategies hold promise as intervention approaches. CONCLUSION: Disparities in controller medication use are pervasive. Identifying the sources of these disparities is a critical step toward generating intervention approaches to enhance disease management among the groups that bear the greatest asthma burden.
OBJECTIVE: Significant disparities exist in asthma outcomes. Racial and ethnic minorities have lower controller medication adherence, which may contribute to differences in asthma morbidity between minority and non-minority groups. The objective of this review is to identify individual, patient-provider communication, and systems issues that contribute to this pattern of medication underuse and to discuss potential strategies for intervention. DATA SOURCES: Data were gathered from numerous sources, including reports of pharmacy and medical records, observational studies, and trials. STUDY SELECTIONS: Studies analyzed factors contributing to patterns of asthma medication adherence that differ by race and ethnicity. RESULTS: There is clear evidence of underuse of asthma controller medications among racial and ethnic minorities in prescription receipt, prescription initiation, and medication use once obtained. Individual factors such as medication beliefs and depressive symptoms play a role. Provider communication is also relevant, including limited discussion of complementary and alternative medicine use, difficulties communicating with patients and caregivers with limited English proficiency, and implicit biases regarding cultural differences. Systems issues (eg, insurance status, cost) and social context factors (eg, exposure to violence) also present challenges. Culturally informed strategies that capitalize on patient strengths and training providers in culturally informed communication strategies hold promise as intervention approaches. CONCLUSION: Disparities in controller medication use are pervasive. Identifying the sources of these disparities is a critical step toward generating intervention approaches to enhance disease management among the groups that bear the greatest asthma burden.
Authors: Jennifer Acosta; Christopher Graves; Elizabeth Spranger; Jacob Kurlander; Anne E Sales; Geoffrey D Barnes Journal: Am J Med Date: 2018-12-03 Impact factor: 4.965
Authors: Jennifer A Lucas; Miguel Marino; Katie Fankhauser; Steffani R Bailey; David Ezekiel-Herrera; Jorge Kaufmann; Stuart Cowburn; Shakira F Suglia; Andrew Bazemore; Jon Puro; John Heintzman Journal: J Asthma Date: 2019-08-22 Impact factor: 2.515
Authors: Jennifer A Lucas; Jorge Kaufmann; Matthew Jones; Arvin Garg; David Ezekiel-Herrera; Jon Puro; Miguel Marino; John Heintzman Journal: J Asthma Date: 2022-03-20
Authors: Rachelle R Ramsey; Jill M Plevinsky; Sophie R Kollin; Robert C Gibler; Theresa W Guilbert; Kevin A Hommel Journal: J Allergy Clin Immunol Pract Date: 2019-12-21
Authors: Sandra E Zaeh; Monica A Lu; Kathryn V Blake; Christabelle Ayensu-Asiedu; Janet T Holbrook; Michelle N Eakin Journal: J Asthma Date: 2021-03-23
Authors: John Heintzman; Jorge Kaufmann; Jennifer Lucas; Shakira Suglia; Arvin Garg; Jon Puro; Sophia Giebultowicz; David Ezekiel-Herrera; Andrew Bazemore; Miguel Marino Journal: J Am Board Fam Med Date: 2020 Sep-Oct Impact factor: 2.657
Authors: Peter G Gibson; Charlene M Prazma; Geoffrey L Chupp; Eric S Bradford; Mark Forshag; Stephen A Mallett; Steve W Yancey; Steven G Smith; Elisabeth H Bel Journal: Respir Res Date: 2021-06-07
Authors: Jean Hunleth; Julie Spray; Sienna Ruiz; Julia Maki; David A Fedele; Sreekala Prabhakaran; Rachel B Forsyth; Cassidy Sykes; Kaylah Crepps; James Shepperd; Deb Bowen; Erika A Waters Journal: J Asthma Date: 2020-10-27 Impact factor: 2.515